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We thank Bulliard and Levi for their interest in our
international population-based survey of women’s perception
of the benefits of mammography screening.1,2 Our survey
showed that in the US and three European countries (UK,
Italy, Switzerland) a high proportion of women overestimated
the benefits that can be expected from screening
mammography.
Bulliard and Levi argue that the questions used in our survey
could not adequately measure perceptions and that simpler,
open-ended questions should have been used. Survey questions
can always be improved, particularly in the light of answers
received, but we do not think that the use of open-ended
questions would have led to different conclusions. For example,
even when classifying the answer that biannual screening in
women older than 50 years reduces breast cancer mortality ‘by
about half’ as correct, 20% (Switzerland) to 38% (US) of
women would overestimate benefits (Table 1 in ref. 2). These
findings are in line with the results of a survey in the Canton of
Geneva conducted in 1998.3
Bulliard and Levi believe that the wording of the question on
whether screening ‘prevents’ or ‘reduces’ the risk of contracting
breast cancer may have been misunderstood and that using
the phrase ‘avoids breast cancer’ would have yielded more
appropriate responses. It is clear that the wording of closed
questions can affect responses4 but the change suggested by
Bulliard and Levi is subtle and unlikely to be of great
importance. The question was asked in four different languages
(English, Italian, German, French) and the frequency with
which women erroneously chose to answer that ‘regular
mammography prevents’ or ‘reduces the risk of breast cancer’
was above 50% in all countries. We think that a more plausible
explanation for these results is the quality of the information
that is disseminated on mammography screening. For example,
an analysis of the contents of leaflets in Australia revealed a
worrying emphasis on cancer incidence, despite the fact that the
incidence of breast cancer is not reduced by screening.5 Similar
results were recently obtained by Jørgensen and Gøtzsche who
investigated relevant websites in Scandinavian and English
speaking countries with national breast cancer screening
programmes.6
Finally, Buillard and Levi disagree with the conclusion that
our results ‘raise doubt on informed consent procedures within
mammography screening programmes’. We agree with Buillard
and Levi that women’s perception will be shaped by several
sources of information, and we acknowledge that we did
not ask about these sources. Nevertheless, women with
misconceptions about mammography who participate in breast
cancer screening programmes may well have given consent that
is not truly informed. Interestingly, the number of correct
answers among British women aged 50–59 (the women in
our study with access to a national screening programme) was
lower compared with women from Switzerland and the US,
where opportunistic screening dominates. In Switzerland, when
using the same question in a survey of women aged 50–69
living in the Morges district of the Canton of Vaud, where a pilot
breast cancer screening programme has been in place since
1995, 80% of respondents believed that that regular
mammography reduces or prevents breast cancer7 compared
with 65% in the national survey.2 These findings may reflect
the dilemma that organized screening programmes face when
attempting both to achieve high coverage and to provide
balanced information.8 Indeed, the quality and the extent of the
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information provided about both the possible benefits and
adverse events of a screening test may dramatically change the
willingness of people to participate.9 We therefore maintain that
the female populations studied in our survey in four countries
appear to be poorly informed about the likely benefit of mam-
mography screening and that many women offered screening
may not be able to exercise informed choice.
References
1 Bulliard JL, Levi F. Re: Women’s perception of the benefits of
mammography screening: Population based survey in four countries.
Int J Epidemiol 2004;33:902–903.
2 Domenighetti G, D’Avanzo B, Egger M et al. Women’s perception of the
benefits of mammography screening: Population based survey in four
countries. Int J Epidemiol 2003;32:816–21.
3 Chamot E, Perneger TV. Misconceptions about efficacy of
mammography screening: a public health dilemma. J Epidemiol
Community Health 2001;55:799–803.
4 Aday LA. Formulating questions about knowledge and attitudes. In:
Aday LA. Designing and Conducting Health Surveys. San Francisco: Jossey-
Bass Publishers, 1991, pp. 175–86.
5 Slaytor EK, Ward JE. How risks of breast cancer and benefits of
screening are communicated to women: analysis of 58 pamphlets. BMJ
1998;317:263–64.
6 Jorgensen KJ, Gotzsche PC. Presentation on websites of possible
benefits and harms from screening for breast cancer: cross sectional
study. BMJ 2004;328:148–54.
7 Domenighetti G. Informed choice in screening. Position paper
prepared for the British National Health Service, 2000.
8 Raffle AE. Information about screening—is it to achieve high uptake or
to ensure informed choice? Health Expect 2001;4:92–98.
9 Domenighetti G, Grilli R, Maggi JR. Does provision of an evidence-
based information change public willingness to accept screening tests?
Health Expect 2000;3:145–50.
doi:10.1093/ije/dyh228
Advance Access publication 26 April 2004
Sirs—A recent paper of Inigo et al. deals with a very interesting
subject: use of the capture-recapture method to estimate the
number of tuberculosis (TB) cases attributable to recent
transmission.1 While estimating numbers of TBcases in the general
population is an important topic, and the capture-recapture
method may be a useful method to achieve this, we believe that the
novel application in the study of Inigo et al. is seriously flawed.
When applying the capture-recapture method in a standard
way, the number of people belonging to different groups or
databases, and the extent to which these databases overlap, are
determined. In the study of Inigo et al., capture-recapture is
used not to get the total number of cases but to get the number
attributable to recent transmission. Below we argue that this
leads to invalid results, because the different databases use
different case definitions of recent transmission, neither of
which is 100% specific.
The amount of recent transmission identified with the two
methods (contact investigation and restriction fragment length
polymorphism [RFLP] results, respectively) was very different.
This is not surprising. Epidemiological contact information has
low sensitivity since casual contacts are often missed, while its
specificity may be limited in high-risk populations.2 If we
understand Inigo et al. correctly, epidemiological identification
of recent transmission in their study had a positive predictive
value of 55% since of 29 contacts with known RFLP results, 16
(55%) were found to be clustered, while 13 were not clustered.
Incidentally, this result should also have been applied to the 20
epidemiologically linked cases without RFLP results available.
RFLP typing on the other hand may have limited sensitivity if
sampling is incomplete3,4 and limited specificity in stable
populations.5,6
In the Table we show a theoretical example of a population
which is completely captured, and in which two tests are used
to identify cases of recent transmission. One test has low
sensitivity (8/30 = 27%) and high specificity (63/70 = 90%)
(epidemiological information on contact) and the other higher
sensitivity (26/30 = 87%) and lower specificity (56/70 = 80%)
(RFLP typing). The Table does not claim that sensitivity and
specificity of these techniques are known to have these values,
but explores the consequences of sub-optimal sensitivity and
specificity of different diagnostic tests if their results are used in
a capture-recapture analysis.
In the Table, A and B summarize the ‘test’ results in a
population in which 30% of cases are attributable to recent
transmission. C and D compare the results of the two tests in
‘true’ positives and ‘true’ negatives, assuming errors in the two
tests are independent (thus, for example, the expected value for
Epi recent transmission = yes and RFLP recent transmission =
yes is (8  26)/30). E provides a comparison of test results in
the total population (by summing C and D), and F applies the
capture-recapture analysis as proposed by Inigo et al. on those
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